North Central Cancer Treatment Group Phase I Trial N057K of Everolimus (RAD001) and Temozolomide in Combination With Radiation Therapy in Patients With Newly Diagnosed Glioblastoma MultiformeJann N. Sarkaria, Jan C. Buckner, Kurt A. Jaeckle et al.|International Journal of Radiation Oncology*Biology*Physics|2010Cited by 89